Looking forward to hearing your udpate ddwn as the "Chairmans...

Looking forward to hearing your udpate ddwn as the "Chairmans Address to Shareholders" confirmed fully another 6 month delay in aGVHD approval - now "hopefully" regulatory approval in first half of next year instead of this year. Commercialisation was supposed to start in Q3 as of 6 months ago which is not going to happen.TBH the 4 year survival rate is nice but we already know it works and works well even after 2 years so 4 years is just a bit of ....ok great 51% to 49% - pretty much the same as 2 year data.

So many time frames not met - I am sure some of it is FDA process, hoops and hurdles for sure but I am always disappointed when MSB update the market on near the last day of the allowable time they have set for an update ie. last day of the quarter, this is not inspiring and feels like delaying tactics which then makes you think..what is really going on with the FDA.

I am a pretty patient person being invested for nearly 7 years but it is starting to get ridiculous the extensions of time for aGVHD.

Still invested and still waiting but please be more of a realist on process and time frames Si. Just the games of publicly held companies and what they have to do to survive.